Apoptosis in breast cancer

Advances in Cell Aging and Gerontology

Volumn 6, Issue C, 2001, Pages 1-22

  Werner, Haim ^a   Oh, Youngman ^a   Roberts Jr , Charles T ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 35448964294     PISSN: 15663124     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1566-3124(01)06001-1     Document Type: Review

References (132)

1. Agarwal M.L., Taylor W.R., Chernov M.V., Chernova O.B., and Stark G.R. The p53 network. J. Biol. Chem. 273 (1998) 1-4
2. Akiyama T., Ishida J., Nakagawa H., Watanabe S., Itoh N., Shibuy A.M., and Fukamo Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262 (1987) 5592-5595
3. Allen R.T., Cluck M.W., and Agrawal D.K. Mechanisms controlling cellular suicide: role of Bcl-2 and caspases. Cell. Mol. Life Sci. 54 (1998) 427-445
4. Atwood C.S., Ikeda M., and Vonderhaar B.K. Involution of mouse mammary glands in whole organ culture: a model for studying programmed dell death. Biochem. Biophys. Res. Comm. 207 (1995) 860-867
5. Bardelli A., Longati P., Albero D., Goruppi S., Schneider C., Ponzetta C., and Comoglio P.M. HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death. EMBO J. 15 (1996) 6205-6212
6. Barres B.A., Hart I.K., Coles H.S., Burne J.F., Voyvodic J.T., Richardson W.D., and Raff M.C. Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70 (1992) 31-46
7. Baselga J., Norton L., Masui H., Pandiella A., Coplan K., Miller W.H., and Mendelsohn J. Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies. J. Natl. Cancer Inst. 85 (1993) 1327-1333
8. Berry M., Metzger D., and Chambon P. Role of the two activating domains of the oestrogen receptor in the cell-type and promoter- context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J. 9 (1990) 2811-2818
9. Buckbinder L., Talbott R., Velasco-Miguel S., Takenaka I., Faha B., Seizinger B.R., and Kley N. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377 (1995) 646-649
10. Burdon T.G., Maitland K.A., Clark A.J., Wallace R., and Watson C.J. Regulation of the sheep β-lactoglobulin gene by lactogenic hormones is mediated by a transcription factor that binds an interferon-γ activation site-related element. Mol. Endo. 8 (1994) 1528-1536
11. Carraway III K.L., Sliwkowski M.X., Akita R., Platko J.V., Guy P.M., Nuijens A., Diamonti A.J., Vandlen R.L., Cantley L.C., and Cerione R.A. The erbB3 gene product is a receptor for heregulin. J. Biol. Chem. 269 (1994) 14303-14306
12. Chai Y.L., Cui J., Shao N., Shyam E., Reddy P., and Rao V.N. The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter. Oncogene 18 (1999) 263-268
13. Chammas R., Taverna D., Cella N., Santos C., and Hynes N.E. Laminin and tenascin assembly and expression regulate HC11 mouse mammary cell differentiation. J. Cell Sci. 107 (1994) 1031-1040
14. Chapman M.S., and Verma I.M. Transcriptional activation by BRCA1. Nature 382 (1996) 678-679
15. Chiu J.J., Sgagias M.K., and Cowan K.H. Interleukin 6 acts as a paracrine growth factor in human mammary carcinoma cell lines. Clin. Cancer Res. 2 (1996) 215-221
16. Cohen G.M. Caspases: the executioners of apoptosis. Biochem. J. 326 (1997) 1-16
17. Coles H., Burne J.F., and Raff M.C. Large scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor. Development 118 (1993) 777-784
18. Cryns V., and Yuan J. Proteases to die for. Genes Dev. 12 (1998) 1551-1570
19. Daniel C.W., and Silberstein G.B. Postnatal development of the rodent mammary gland. In: Neville M.C., and Daniel C.W. (Eds). The Mammary Gland: Development, Regulation and Function (1985), Plenum Publishing, New York 3-36
20. Detre S., Salter J., Barnes D.M., Riddler S., Hills M., Johnston S.R., Gillett C., A'Hern R., and Dowsett M. Time-related effects of estrogen withdrawal on proliferation- and cell death-related events in MCF-7 xenografts. Int. J. Cancer 81 (1999) 309-313
21. Early Breast Cancer Trials Group (EBCTG). Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31000 recurrences and 2400 deaths among 75000 women. Lancet 339 (1992) 1-15
22. Early Breast Cancer Trials Group (EBCTG). Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31000 recurrences and 2400 deaths among 75000 women. Lancet 339 (1992) 71-85
23. Eck K.M., Yuan L., Duffy L., Ram P.T., Ayettey S., Chen I., Cohn C.S., Reed J.C., and Hill S.M. A sequential treatment regimen with melatonin and all-trans retinoic acid induces apoptosis in MCF-7 tumour cells. Brit. J. Cancer 77 (1998) 2129-2137
24. Ellis P.A., Saccani-Jotti G., Clarke R., Johnston S.R.D., Anderson E., Howell A., A'hern R., Salter J., Detre S., Nicholson R., Robertson J., Smith I.E., and Dowsett M. Induction of apoptosis by tamoxifen and ICI 182789 in primary breast cancer. Int. J. Cancer 72 (1997) 608-613
25. Ellisen L.W., and Haber D.A. Hereditary breast cancer. Annu. Rev. Med. 49 (1998) 425-436
26. Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A., and Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391 (1998) 43-50
27. Evan G., and Littlewood T. A matter of life and cell death. Science 281 (1998) 1317-1322
28. Fanjul A.N., Piedrafita F.J., Al-Shamma H., and Pfahl M. Apoptosis induction and potent antiestrogen receptor-negative breast cancer activity in vivo by a retinoid antagonist. Cancer Res. 58 (1998) 4607-4610
29. Fattman C.L., An B., Sussman L., and Dou Q.P. p53-independent dephosphorylation and cleavage of retinoblastoma protein during tamoxifen-induced apoptosis in human breast carcinoma cells. Cancer Lett. 130 (1998) 103-113
30. Feng Z., Marti A., Jehn B., Altermatt H.J., Chicaiza G., and Jaggi R. Glucocorticoid and progesterone inhibit involution and programmed cell death in the mouse mammary gland. J. Cell Biol. 131 (1995) 1096-1103
31. Fioravanti L., Cappelletti V., Miodini P., Ronchi E., Brivio M., and Di Fronzo G. Genistein in the control of breast cancer cell growth: insights into the mechanism of action in vitro. Cancer Lett. 130 (1998) 143-152
32. Fisher D.E. Apoptosis in cancer therapy: crossing the threshold. Cell 78 (1994) 539-542
33. Fotsis T., Pepper M., Adlercreutz H., Fleischmann G., Hase T., Montesano R., and Schweigerer L. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc. Natl. Acad. Sci. USA 90 (1993) 2690-2694
34. Glebov O.K., McKenzie K.E., White C.A., and Sukumar S. Frequent p53 gene mutations and novel alleles in familial breast cancer. Cancer Res. 54 (1994) 3703-3709
35. Gooch J.L., Lee A.V., and Yee D. Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells. Cancer Res. 58 (1998) 4199-4205
36. Grothey A., Voigt W., Schober C., Muller T., Dempke W., and Schmoll H.J. The role of insulin-like growth factor I and its receptor in cell growth, transformation, apoptosis, and chemoresistance in solid tumors. J. Cancer Res. Clin. Oncol. 125 (1999) 166-173
37. Gucev Z.S., Oh Y., Kelley K.M., and Tosenfeld R.G. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor β2-induced growth inhibition in human breast cancer cells. Cancer Res. 56 (1996) 1545-1550
38. Guenette R.S., Corbeil H.B., Leger J., Wong K., Mezl V., Mooibroek M., and Tenniswood M. Induction of gene expression during involution of lactating mammary gland of the rat. J. Mol. Endocrinol. 12 (1994) 47-60
39. Haldar S., Negrini M., Monne M., Sabbioni S., and Croce C.M. Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res. 54 (1994) 2095-2097
40. Hankinson S.E., Willett W.C., Colditz G.A., Hunter D.J., Michaud D.S., Deroo B., Rosner B., Speizer R.E., and Pollak M. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351 (1998) 1393-1396
41. Harkin D.P., Bean J.M., Miklos D., Song Y.H., Truong V.B., Englert C., Christians F.C., Ellisen L.W., Maheswaran S., Oliner J.D., and Haber D.A. Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1. Cell 97 (1999) 575-586
42. s are induced at the onset of apoptosis in involuting mammary epithelial cells. Mech. Dev. 56 (1996) 197-207
43. Hemsell D.L., Grodin J., Breuner P.F., Siiteri P.K., and MacDonald P.C. Plasma precursors of estrogen II. Correlation of the extent of conversion of plasma androstenedione to estrone with age. J. Clin. Endocrinol. Metab. 38 (1974) 376-379
44. Hetts S.W. To die or not to die. J. Am. Med. Assoc. 279 (1998) 300-307
45. Hockenberry D., Nunez G., Milliman C., Schreiber R.D., and Korsmeyer S.J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348 (1990) 334-336
46. Howell A., DeFriend D., Robertson J., Blamey R., and Walton P. Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer. Lancet 345 (1995) 29-30
47. Huang Y., Ray S., Reed J.C., Ibrado A.M., Tang C., Nawabi A., and Bhalla K. Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells. Breast Cancer Res. Treat. 42 (1997) 73-81
48. Humphreys R.C., Krajewska M., Krnacik S., Jaeger R., Weiher H., Krajewski S., Reed J.C., and Rosen J.M. Apoptosis in the terminal endbud of the murine mammary gland: a mechanism of ductal morphogenesis. Development 122 (1996) 4013-4022
49. Huynh H., Yang X., and Pollak M. Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells. J. Biol. Chem. 271 (1996) 1016-1021
50. Hynes R.O. Integrins: versatility, modulation and signaling in cell adhesion. Cell 69 (1992) 11-25
51. Kato H., Faria T.N., Stannard N., Roberts C.T., and LeRoith D. Role of the tyrosine kinase domain in signal transduction by the insulin-like growth factor-I receptor. J. Biol. Chem. 268 (1995) 2655-2661
52. Kiess W., and Gallaher B. Hormonal control of programmed cell death/apoptosis. Eur. J. Endocrinol. 138 (1998) 482-491
53. Kluck R.M., Bossy-Wetzel E., Green D.R., and Newmeyer D.D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275 (1997) 1132-1136
54. Knudson C.M., Tung K.S., Tourtellotte W.G., Brown G.A., and Korsmeyer S.J. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270 (1995) 96-99
55. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med. 3 (1997) 614-620
56. Kulik G., Klippel A., and Weber M.J. Antiapoptotic signaling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase. Akt. Mol. Cell. Biol. 17 (1997) 1595-1606
57. Kulik G., and Weber M.J. Akt-dependent and independent survival signaling pathways utilized by insulin-like growth factor I. Mol. Cell. Biol. 18 (1998) 6711-6718
58. Kumar R., Mandal M., Lipton A., Harvey H., and Thompson C.B. Overexpression of HER2 modulates bcl-2, bcl-XL, and tamoxifen-induced apoptosis in human MCF-7 breast cancer cells. Clin. Cancer Res. 2 (1996) 1215-1219
59. Leung L.K., Do L., and Wang T.T. Regulation of death promoter Bak, expression by cell density and 17 beta-estradiol in MCF-7 cells. Cancer Lett. 124 (1998) 47-52
60. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell 88 (1997) 323-331
61. Li F.P., and Fraumeni Jr. J.F. Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?. Ann. Intern. Med. 71 (1969) 747-752
62. Li M., Liu X., Robinson G., Bar-Peled U., Wagner K.-U., Young W.S., Hennighausen L., and Furth P.A. Mammary-derived signals activate programmed cell death during the first stage of mammary gland involution. Proc. Natl. Acad. Sci. USA 94 (1997) 3425-3430
63. Li S., and Rosen J.M. Nuclear factor I and mammary gland factor (STAT5) play a critical role in regulating rat whey acidic protein gene expression in transgenic mice. Mol. Cell. Biol. 15 (1995) 2063-2070
64. Lin X., Zou H., Slaughter C., and Wang X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89 (1997) 175-184
65. Lund L.R., Romer J., Thomasset N., Solberg H., Pyke C., Bissell M.J., Dano K., and Werb Z. Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways. Development 122 (1996) 181-193
66. Lupu R., Cardillo M., Cho C., Harris L., Hijazi M., Perez C., Rosenberg K., Yang D., and Tang C. The significance of heregulin in breast cancer tumor progression and drug resistance. Breast Cancer Res. Treat. 38 (1996) 57-66
67. Lupulescu A.P. Hormones, vitamins, and growth factors in cancer treatment and prevention. Cancer 78 (1996) 2264-2280
68. Markovits J., Linassier C., Fosse P., Couprie J., Pierre J., Jacquemin-Sablon A., Saucier J.M., Le Pecq J.B., and Larsen A.K. Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res. 49 (1989) 5111-5117
69. McCloskey D.E., Armstrong D.K., Jackisch C., and Davidson N.E. Programmed cell death in human breast cancer cells. Recent Prog. Horm. Res. 51 (1996) 493-508
70. Merlo G.R., Cella N., and Hynes N.E. Apoptosis is accompanied by changes in Bcl-2 and Bax expression, induced by loss of attachment, and inhibited by specific extracellular matrix proteins in mammary epithelial cells. Cell Growth Differ. 8 (1997) 251-260
71. Miki Y., Swensen J., Shattuck-Eidens D., Futreal P.A., Harshman K., Tavtigian S., Liu Q., Cochran C., Bennett L.M., Ding W., et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266 (1994) 66-71
72. Miller W.R. Uptake and synthesis of steriod hormones by the breast. Endocrinology Related Cancer 4 (1997) 307-312
73. Milner J., Ponder B., Hughes-Davies L., Seltmann M., and Kouzarides T. Transcriptional activation functions in BRCA2. Nature 386 (1997) 772-773
74. Miyashita T., Krajewski S., Krajewska M., Wang H.G., Lin H.K., Liebermann D.A., Hoffman B., and Reed J.C. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9 (1994) 1799-1805
75. Miyashita T., and Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80 (1995) 293-299
76. Nass S.J., Li M., Amundadottir L.T., Furth P.A., and Dickson R.B. Role for Bcl-xL in the regulation of apoptosis by EGF and TGF beta 1 in c-myc overexpressing mammary epithelial cells. Biochem. Biophys. Res. Comm. 227 (1996) 248-256
77. Nicholson D.W., and Thornberry N.A. Caspases: killer proteases. Trends Biochem. Sci. 22 (1997) 299-306
78. Nickerson T., Huynh H., and Pollak M. Insulin-like growth factor binding protein-3 induces apoptosis in MCF-7 breast cancer cells. Bioch. Biophys. Res. Comm. 237 (1997) 690-693
79. Oh Y., Muller H.L., Ng L., and Rosenfeld R.G. Transforming growth factor-beta-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein 3. J.. Biol. Chem. 270 (1995) 13589-13592
80. Oh Y. IGF-indenpendent regulation of breast cancer growth by IGF binding proteins. Breast Cancer Res. 47 (1998) 283-293
81. Oltvai Z.N., Milliman C.L., and Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74 (1993) 609-619
82. Ossowski L., Biegel D., and Reich E. Mammary plasminogen activator, correlation with involution, hormonal modulation and comparison between normal and neoplastic tissue. Cell 16 (1979) 929-940
83. Pan G., O'Rourke K., and Dixit V.M. Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex. J. Biol. Chem. 273 (1998) 5841-5845
84. Parrizas M., and LeRoith D. Insulin-like growth factor-1 inhibition of apoptosis is associated with increased expression of the bcl-xL gene product. Endocrinology 138 (1997) 1355-1358
85. Peles E., Ben-Levy R., Or E., Ullrich A., and Yarden Y. Oncogenic forms of the neu/HER2 tyrosine kinase are permanently coupled to phospholipase Cγ. EMBO J. 10 (1991) 2077-2086
86. Petersen O.W., Ronnov-Jessen L., Weaver V.M., and Bissell M.J. Differentiation and cancer in the mammary gland: shedding light on an old dichotomy. Adv. Cancer Res. 75 (1998) 135-161
87. Pfahl M., Apfel R., Bendik I., Fanjul A., Graupner G., Lee M.O., La Vista N., Lu X.P., Piedrafita F.J., Ortiz M.A., Salbert G., and Zhang X.K. Nuclear retinoid receptors and their mechanism of action. Vitam. Horm. 49 (1994) 327-382
88. Philp J.A.C., Burdon T.G., and Watson C.J. Differential activation of STATs 3 and 5 during mammary gland development. FEBS Lett. 396 (1996) 77-80
89. Pietenpol J.A., Tokino T., Thiagalingam S., El-Deiry W.S., Kinzler K.W., and Vogelstein B. Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc. Natl. Acad. Sci. USA 91 (1994) 1998-2002
90. Puget N., Stoppa-Lyonnet D., Sinilnikova O.M., Pages S., Lynch H.T., Lenoir G.M., and Mazoyer S. Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions. Cancer Res. 59 (1999) 455-461
91. Pullan S., Wilson J., Metcalfe A., Edwards G.M., Goberdhan N., Tilly J., Hickman J.A., Dive C., and Streuli C.H. Requirement of basement membrane for the suppression of programmed cell death in mammary epithelium. J. Cell Sci. 109 (1996) 631-642
92. Quarrie L.H., Addey C.V.P., and Wilde C.J. Apoptosis in lactating and involuting mouse mammary tissue demonstrated by nick-end DNA labeling. Cell Tissue Res. 281 (1995) 413-419
93. Rajah R., Valentinis B., and Cohen P. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism. J. Biol. Chem. 272 (1997) 12181-12188
94. Reed J.C. Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Curr. Opin. Oncol. 7 (1995) 541-546
95. Ronnov-Jessen L., Petersen O.W., and Bissell M.J. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol. Rev. 76 (1996) 69-125
96. Roskelley C.D., Srebow A., and Bissell M.J. A hierarchy of ECM-mediated signaling regulates tissue-specific gene expression. Curr. Opin. Cell Biol. 7 (1995) 736-747
97. Rozen F., Zhang J., and Pollak M. Antiproliferative action of tumor necrosis factor-α on MCF-7 breast cancer cells is associated with increased insulin-like growth factor binding protein-3 accumulation. Int. J. Oncol. 13 (1998) 865-869
98. Sakamuro D., Sabbatini P., White E., and Prendergast G.C. The polyproline region of p53 is required to activate apoptosis but not growth arrest. Oncogene 15 (1997) 887-898
99. Scully R., Chen J., Plug A., Xiao Y., Weaver D., Feunteun J., Ashley T., and Livingston D.M. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88 (1997) 265-275
100. Setchell K.D.R., and Adlercreutz H. Mammalian lignans and phytoestrogens. Recent studies on their formation, metabolism and biological roles in health and disease. In: Rowland I.R. (Ed). Role of the gut flora in toxicity and cancer (1988), Academic Press, London 315-345
101. Shao N., Chai Y.L., Shyam E., Reddy P., and Rao V.N. Induction of apoptosis by the tumor suppressor protein BRCA1. Oncogene 13 (1996) 1-7
102. Sharan S.K., Morimatsu M., Albrecht U., Lim D.S., Regel E., Dinh C., Sands A., Eichele G., Hasty P., and Bradley A. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 386 (1997) 804-810
103. Shimizu S., Narita M., and Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399 (1999) 483-487
104. Sidransky D., Tokino T., Helzlsouer K., Zehnbauer B., Rausch G., Shelton B., Prestigiacomo L., Vogelstein B., and Davidson N. Inherited p53 gene mutations in breast cancer. Cancer Res. 52 (1992) 2984-2986
105. Singleton J.R., Dixit V.M., and Feldman E.L. Type I insulin-like growth factor receptor activation regulates apoptotic proteins. J. Biol. Chem. 271 (1996) 31791-31794
106. Soussi T. The p53 tumour suppressor gene: from molecular biology to clinical investigation. In: Cowell J. (Ed). Molecular Genetics of Cancer (1995), Bios. Scientific 135-178
107. Soussi T. The p53 tumor suppressor gene: a model for molecular epidemiology of human cancer. Mol. Med. Today 2 (1996) 32-37
108. Staiger H., and Loffler G. The role of PDGF-dependent suppression of apoptosis in differentiating 3T3-L1 preadipocytes. Eur. J. Cell Biol. 77 (1998) 220-227
109. Streuli C.H. Basement membrane as a differentiation and survival factor. In: Ekblom P. (Ed). The Laminins (1995), Harwood Academic Publishers, Switzerland 217-233
110. Surmacz E., Guvakova M.A., Nolan M.K., Nicosia R.F., and Sciacca L. Type I insulin-like growth factor receptor function in breast cancer. Breast Cancer Res. Treat. 47 (1998) 255-267
111. Tatarczuch L., Philip C., and Lee C.S. Involution of the sheep mammary gland. J. Anat. 190 (1997) 405-416
112. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science 267 (1995) 1456-1462
113. Thornberry N.A., and Lazebnik Y. Caspases: enemies within. Science 281 (1998) 1312-1316
114. Toi M., Bicknell R., and Harris A.L. Inhibition of colon and breast carcinoma cell growth by interleukin-4. Cancer Res. 55 (1992) 275-279
115. Topper Y.J., Oka T., and Vonderhaar B.K. Techniques for studying development of normal mammary cells in culture. Methods Enzymol. 39 (1975) 443-454
116. Tsujimoto Y., Cossman J., Jaffe E., and Croce C.M. Involvement of the bcl-2 gene in human follicular lymphoma. Science 228 (1985) 1440-1443
117. Vaux D.L., Cory S., and Adams J.M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c- myc to immortalize pre-B cells. Nature 335 (1988) 440-442
118. Veis D.J., Sorenson C.M., Shutter J.R., and Korsmeyer S.J. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75 (1993) 229-240
119. Wang H., Shao N., Ding Q.M., Cui J., Reddy E.S., and Rao V.N. BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases. Oncogene 15 (1997) 143-157
120. Wang L., Ma W., Markovich R., Lee W.-L., and Wang P.H. Insulin-like growth factor I modulates induction of apoptotic signaling in H9C2 cardiac muscle cells. Endocrinology 139 (1998) 1354-1360
121. Wang Q., Maloof P., Wang H., Fenig E., Stein D., Nichols G., Denny T.N., Yahalom J., and Wieder R. Basic fibroblast growth factor downregulates Bcl-2 and promotes apoptosis in MCF-7 human breast cancer cells. Exp. Cell Res. 238 (1998) 177-187
122. Watson C.J., Gordon K.E., Robertson M., and Clark A.J. Interaction of DNA-binding proteins with a milk protein gene promoter in vitro: identification of a mammary gland-specific factor. Nucleic Acids Res. 19 (1991) 6603-6610
123. Weinstein E.J., Grimm S., and Leder P. The oncogene heregulin induces apoptosis in breast epithelial cells and tumors. Oncogene 17 (1998) 2107-2113
124. Williams J.M., and Daniel C.W. Mammary ductal elongation: differentiation of myoepithelium and basal lamina during branching morphogenesis. Dev. Biol. 97 (1983) 274-290
125. Wilson C.A., Ramos L., Villasenor M.R., Anders K.H., Press M.F., Clarke K., Karlan B., Chen J.J., Scully R., Livingston D., Zuch R.H., Kanter M.H., Cohen S., Calzone F.J., and Slamon D.J. Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nat. Genet. 21 (1999) 236-240
126. Wooster R., Bignell G., Lancaster J., Swift S., Seal S., Mangion J., Collins N., Gregory S., Gumbs C., and Micklem G. Identification of the breast cancer susceptibility gene BRCA2. Nature 378 (1995) 789-792
127. L and Bcl-2, displaces Bax and promotes cell death. Cell 80 (1995) 285-291
128. Yu W., Heim K., Qian M., Simmons-Menchaca M., Sanders B.G., and Kline K. Evidence for role of transforming growth factor-beta in R-alpha-tocopheryl succinate-induced apoptosis of human MDA-MB-435 breast cancer cells. Nutr. Cancer 27 (1997) 267-278
129. Yuan J., Shaham S., Ledoux S., Ellis H.M., and Horvitz H.R. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 75 (1993) 641-652
130. Zhang G.J., Kimijima I., Abe R., Watanabe T., Kanno M., Hara K., and Tsuchiya A. Apoptotic index correlates to bcl-2 and p53 protein expression, histological grade and prognosis in invasive breast cancers. Anticancer Res. 18 (1998) 1989-1998
131. Zhang G.J., Kimijima I., Tsuchiya A., and Abe R. The role of bcl-2 expression in breast carcinomas. Oncol. Rep. 5 (1998) 1211-1216
132. Zhang H., Somasundaram K., Peng Y., Tian H., Bi D., Weber B.L., and El-Deiry W.S. BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene 16 (1998) 1713-1721